The Ben Towne Center’s vision includes becoming a hub of clinical studies that help researchers understand and explore innovative treatments for a variety of childhood cancers.
Participants in these studies can take advantage of new therapies before they are widely available and help others by contributing to research. To find out more about the clinical studies process, and its potential benefits and risks, read this guide to clinical studies.
You can search by diagnosis for many clinical trials available through Seattle Children’s and its partners on Fred Hutchinson Cancer Research Center’s clinical trials page.
Current Ben Towne Center trials are listed below.
Phase I Clinical Trials for Leukemia
The Ben Towne Center is currently conducting Phase I clinical trials that uses modified autologous T cells to treat patients with relapsed acute lymphoblastic leukemia (ALL). Learn more.